The Benchmark Company
http://www.benchmarkcap.com/default.aspThe Benchmark Company, a full-service Broker Dealer, provides financial services to institutional and private clients. Its services include private placements, venture capital, M&A services, recapitalizations, divestitures & spin-offs, equity research as well as other financial services. The firm’s equity research division specializes in the media, energy, enterprise software, infrastructure software, and biotechnology & specialty pharmaceutical sectors.
View Older Stories View More Recent Stories
-
Intensity Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds
-
GEN Restaurant Group Announces Pricing of Its Upsized Initial Public Offering at $12.00 per Share
-
Veolia North America Earns Intel’s 2023 EPIC Distinguished Supplier Award
-
DayDayCook Announces F1-Filing for NYSE Listing
-
Movano Health Announces Closing of $9.2 Million Public Offering Including Full Exercise of Over-Allotment Option
-
Cineverse Corp (CNVS) Prices 2.67M Share Offering at $3/sh
-
Cineverse Announces Pricing of $8 Million Public Offering
-
Cineverse Corp (CNVS) Announces Proposed Public Offering of Common Stock, Warrants
-
Cineverse Announces Proposed Public Offering
-
Movano (MOVE) Prices 8M Share Offering at $1/sh
-
Movano Health Prices $8.0 Million Public Offering
-
Movano (MOVE) Announces Proposed Stock Offering, Size not Disclosed
-
Movano Health Announces Proposed Public Offering
-
Genelux (GNLX) Announces 900K Share Private Placement at $20/sh
-
Genelux Corporation Announces $18 Million Private Placement
-
Conduent Named to Newsweek’s Top 100 Global Most Loved Workplaces for 2023
-
Veolia Academy Launches Free Online Training Program To Earn State Licenses For Well-Paying Water Jobs
-
Peraso Inc. (PRSO) Prices 5.71M Share Offering at $0.70/sh
-
Peraso Announces $4.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Orgenesis to Participate in Benchmark’s 3rd Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023
-
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023
-
Tenon Medical, Inc. to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023
-
NUTEX HEALTH TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
-
Genelux (GNLX) Announces 1.67M Share Private Placement at $20/sh
-
Genelux Corporation Announces $33 Million Private Placement
-
Molekule Group, Inc. Announces Closing of $10.0 Million Private Placement and Deferral of $6.0 million Principal Amortization Through 2025
-
Expedia Group beats Street estimates on record lodging bookings
-
Veolia Environnement: Another Quarter of Strong Revenue and Results Growth
-
Molekule Group (MKUL) Announces $10.0 Million Private Placement And Amends Loan Agreements
-
HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference
-
HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference
-
ZyVersa Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering
-
ZyVersa Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering
-
Veolia Environnement: Combined Shareholders' General Meeting, April 27, 2023
-
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conference
-
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conference
-
ZyVersa Therapeutics (ZVSA) Prices 11M Share Offering at $1/sh
-
ZyVersa Therapeutics, Inc. Announces Pricing of $11.0 Million Public Offering
-
ZyVersa Therapeutics, Inc. Announces Pricing of $11.0 Million Public Offering
-
Jayud Global Logistics Limited Announces Closing of Initial Public Offering
-
Sphere 3D Completes Private Placement with LDA Capital
-
Jayud Global Logistics (JYD) Prices 1.25M Share IPO at $4/sh
-
Jayud Global Logistics Limited Announces Pricing of Initial Public Offering
-
CytoMed Therapeutics Limited Announces Closing of US$9,649,476 Firm Commitment Initial Public Offering
-
CytoMed Therapeutics (GDTC) Prices 2.41M Share IPO at $4/sh
-
CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering
-
Allied Gaming & Entertainment Announces Fourth Quarter and Full Year 2022 Financial Results
-
Lucas GC Limited (LGCL) Announces 750K Share IPO at $8-$9/sh
-
Jayud Global Logistics Limited (JYD) Announces 1.5M Share IPO at $4-$5/sh
-
ICZOOM Group Inc. Announces Closing of US$6 Million Initial Public Offering

